SILO PHARMA, INC. Interest and Dividend Income, Operating
SILO PHARMA, INC. (SILO) reported Interest and Dividend Income, Operating of $64.39 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InterestAndDividendIncomeOperating · last filed 2023-05-12
- SILO PHARMA, INC. interest and dividend income, operating for the quarter ending 2023-03-31 was $64.39K, a 15415.18% increase year-over-year.
- SILO PHARMA, INC. interest and dividend income, operating for the quarter ending 2022-03-31 was $415.00.
- SILO PHARMA, INC. interest and dividend income, operating for fiscal 2022 was $72.64K, a 5903.06% increase from fiscal 2021.
- SILO PHARMA, INC. interest and dividend income, operating for fiscal 2021 was $1.21K.
| Period end | Interest and Dividend Income, Operating 3 month | Interest and Dividend Income, Operating 12 month |
|---|---|---|
| 2023-03-31 | $64.39K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $72.64K 10-K · filed 2023-03-24 | |
| 2022-03-31 | $415.00 10-Q · filed 2023-05-12 | |
| 2021-12-31 | $1.21K 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |